Non-Ablative Laser for Scarring Alopecia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test whether a 1470nm non-ablative fractional laser can effectively treat scarring alopecia, a condition where scarring causes permanent hair loss. Researchers seek to understand the laser's effects on hair follicles at a molecular level by examining changes before and after treatment. Participants will receive three laser treatments, and hair samples will be taken to analyze these changes. Individuals diagnosed with scarring alopecia, who have experienced stable hair loss for at least three months, and who do not plan to change their hair treatment routine may be suitable for this trial. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new treatment options for scarring alopecia.
Do I need to stop my current medications for the trial?
The trial requires that you do not start any new medications for hair loss, like minoxidil, during the study. However, it does not specify if you need to stop other current medications, but you must have a stable hair loss treatment regimen for at least 3 months before joining.
What prior data suggests that this non-ablative laser is safe for treating scarring alopecia?
Research has shown that the 1470 nm non-ablative laser is generally safe for people. In past studies, this laser treated conditions like acne scars and proved to be safe and well-tolerated, with no major side effects reported.
For conditions similar to scarring alopecia, such as androgenetic alopecia, the 1470 nm laser was also tested and found to be safe. Patients did not experience significant side effects during these tests. This suggests that the laser treatment might also be safe for people with scarring alopecia.
In summary, past studies indicate that this laser treatment is usually safe and easy for people to handle. Participants didn't report serious side effects, which is encouraging for those considering joining a clinical trial for scarring alopecia.12345Why are researchers excited about this trial?
Researchers are excited about the 1470nm non-ablative fractional laser for scarring alopecia because it offers a unique approach compared to standard treatments like corticosteroids and immunosuppressants. This laser treatment works by gently resurfacing the skin without removing layers, which could potentially stimulate hair regrowth and improve scalp health. Unlike more invasive procedures, this method involves minimal downtime and discomfort, making it a promising option for those seeking less aggressive treatment for scarring alopecia.
What evidence suggests that this laser treatment might be effective for scarring alopecia?
Research has shown that certain lasers, such as non-ablative fractional lasers, may help treat hair loss conditions like male and female pattern baldness. In this trial, participants with scarring alopecia will receive treatments with the 1470 nm non-ablative fractional laser. Although limited data from human studies exist specifically for scarring alopecia, these lasers target affected hair follicles and might reduce inflammation and scarring. The 1470 nm laser delivers energy to the skin without damaging the surface, potentially aiding hair regrowth. Early findings suggest this method might increase hair thickness and coverage. More research is needed to confirm these effects specifically for scarring alopecia, but initial results appear promising.26789
Who Is on the Research Team?
Kseniya Kobets, MD
Principal Investigator
Albert Einstein College of Medicine Montefiore Medical Center
Are You a Good Fit for This Trial?
This trial is for adults with scarring alopecia, a condition where scar tissue replaces hair follicles leading to permanent hair loss. Participants must be willing to undergo three laser treatments and attend follow-up visits. They should also agree to provide hair samples for analysis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 3 laser treatments, spaced 1 month apart, using the non-ablative Sciton HALO laser (1470nm) for scarring alopecia
Follow-up
Participants attend follow-up visits for clinical assessments, including hair density evaluation and gene expression analysis
What Are the Treatments Tested in This Trial?
Interventions
- 1470nm non-ablative fractional laser
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
Sciton
Industry Sponsor
American Society for Laser Surgery and Medicine
Collaborator